0.8203
price up icon0.00%   0.00
after-market After Hours: .82 -0.0003 -0.04%
loading
Cue Biopharma Inc stock is traded at $0.8203, with a volume of 147.27K. It is up +0.00% in the last 24 hours and up +10.70% over the past month. Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
See More
Previous Close:
$0.8203
Open:
$0.8162
24h Volume:
147.27K
Relative Volume:
0.48
Market Cap:
$61.81M
Revenue:
$9.53M
Net Income/Loss:
$-44.61M
P/E Ratio:
-0.9014
EPS:
-0.91
Net Cash Flow:
$-38.32M
1W Performance:
-8.75%
1M Performance:
+10.70%
6M Performance:
-38.78%
1Y Performance:
+26.82%
1-Day Range:
Value
$0.805
$0.84
1-Week Range:
Value
$0.805
$0.92
52-Week Range:
Value
$0.45
$1.9891

Cue Biopharma Inc Stock (CUE) Company Profile

Name
Name
Cue Biopharma Inc
Name
Phone
617-949-2680
Name
Address
40 GUEST STREET, BOSTON, MA
Name
Employee
41
Name
Twitter
@cuebiopharma
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
CUE's Discussions on Twitter

Compare CUE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CUE
Cue Biopharma Inc
0.8203 61.81M 9.53M -44.61M -38.32M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-13-24 Initiated Jefferies Buy
Jun-26-23 Resumed Oppenheimer Outperform
Nov-21-22 Initiated Piper Sandler Overweight
Jan-13-22 Initiated H.C. Wainwright Buy
Jan-03-22 Initiated Craig Hallum Buy
Nov-24-20 Initiated Berenberg Buy
Apr-09-20 Initiated Stifel Buy
Jan-28-20 Initiated BTIG Research Buy
Jan-22-20 Initiated JMP Securities Mkt Outperform
View All

Cue Biopharma Inc Stock (CUE) Latest News

pulisher
Jul 29, 2025

What makes Cue Biopharma Inc. stock price move sharplyLoss Limitation Strategy Based on Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How Cue Biopharma Inc. stock performs during market volatilityTrade Safety Matrix for Conservative Traders - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Will Cue Biopharma Inc. stock benefit from interest rate changesBreakout Confirmation With Entry Tracker Enabled - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Why Cue Biopharma Inc. stock attracts strong analyst attentionFree Risk Adjusted Technical Entry Plan - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Why Cue Biopharma Inc. stock is on top investor watchlistsWeekly Stock Picks with Trend Confidence - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Can machine learning forecast Cue Biopharma Inc. recoveryFree Weekly Setup With 3x Return Potential - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Buy Signal for Cue Biopharma Inc. Stock Key Technical Indicators to WatchEarnings Impact and Stock Reaction Analysis - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How did CUE's Q4 earnings surprise impact investor confidence? - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Using data models to predict Cue Biopharma Inc. stock movementEntry Timing Tracker with Alert Accuracy - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

What technical models suggest about Cue Biopharma Inc.’s comebackMarket Opportunity Tracker for Swing Traders - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 23:49:57 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Cue Biopharma Inc. Flashes Buy Signal on Multi Timeframe ChartCommunity Strategy With High Win Rate Backtested - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Cue Biopharma Inc. in the next 12 monthsExplosive market performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the latest earnings results for Cue Biopharma Inc.Stay ahead with advanced stock screening tools - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Earnings visualization tools for Cue Biopharma Inc.Weekly Gain Forecast with Momentum Indicators - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How does Cue Biopharma Inc. compare to its industry peersUnlock expert trading strategies for growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Using AI based signals to follow Cue Biopharma Inc.Weekly Signal Report with Trend Summary - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive Cue Biopharma Inc. stock higher in 2025Breakthrough capital growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Cue Biopharma Inc. stock overvalued or undervaluedGet high-impact stock recommendations now - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Cue Biopharma Inc. Stock Support and Resistance Levels You Should KnowOptimized Return Investment Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Intrinsic Value of Cue Biopharma Inc. Stock: Is It Undervalued or OvervaluedSafety First Trading Signals - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

why cue biopharma inc. stock attracts strong analyst attentionCapital Doubling Tips - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Will Cue Biopharma Inc. stock split in the near futureConsistently high yield - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Cue Biopharma Inc. stockConsistently outstanding ROI - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Cue Biopharma Inc. stock outlookFree Consultation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Cue Biopharma Inc. stock priceFree High-Return Strategy Alerts - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Pancreatic Cancer Market to Show Remarkable Growth Trends from - openPR.com

Jul 23, 2025
pulisher
Jul 23, 2025

High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds - Benzinga

Jul 23, 2025
pulisher
Jul 23, 2025

Is Cue Biopharma Inc. a good long term investmentBreakthrough profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Cue Biopharma Inc. Stock Analysis and ForecastPhenomenal investment performance - jammulinksnews.com

Jul 22, 2025

Cue Biopharma Inc Stock (CUE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Cap:     |  Volume (24h):